Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Laninamivir Octanoate

    ACTIVE PHARMA INGREDIENTS

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: Mcg28bi87w, 1233643-88-3, Inavir, Laninamivir octanoate hydrate, Laninamivir octanoate hydrate (jan), Laninamivir octanoate hydrate [jan]
    Molecular Formula
    C21H38N4O9
    Molecular Weight
    490.5  g/mol
    InChI Key
    IBFFAVWCRFPPNZ-QZAMVOJNSA-N
    FDA UNII
    MCG28BI87W
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-2-hydroxy-1-methoxy-3-octanoyloxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid;hydrate
    2.1.2 InChI
    InChI=1S/C21H36N4O8.H2O/c1-4-5-6-7-8-9-16(28)32-11-14(27)18(31-3)19-17(24-12(2)26)13(25-21(22)23)10-15(33-19)20(29)30;/h10,13-14,17-19,27H,4-9,11H2,1-3H3,(H,24,26)(H,29,30)(H4,22,23,25);1H2/t13-,14+,17+,18+,19+;/m0./s1
    2.1.3 InChI Key
    IBFFAVWCRFPPNZ-QZAMVOJNSA-N
    2.1.4 Canonical SMILES
    CCCCCCCC(=O)OCC(C(C1C(C(C=C(O1)C(=O)O)N=C(N)N)NC(=O)C)OC)O.O
    2.1.5 Isomeric SMILES
    CCCCCCCC(=O)OC[C@H]([C@H]([C@H]1[C@@H]([C@H](C=C(O1)C(=O)O)N=C(N)N)NC(=O)C)OC)O.O
    2.2 Other Identifiers
    2.2.1 UNII
    MCG28BI87W
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 5-(acetylamino)-4-((aminoiminomethyl)amino)-2,6-anhydro-3,4,5-trideoxy-7-o-methyl-d-glycero-d-galacto-non-2-enonic Acid

    2. Laninamivir

    3. Laninamivir Octanoate

    4. Laninamivir Octanoate Hydrate

    5. Laninamivir Trifluoroacetate

    6. R 125489

    7. R-125489

    8. R125489

    2.3.2 Depositor-Supplied Synonyms

    1. Mcg28bi87w

    2. 1233643-88-3

    3. Inavir

    4. Laninamivir Octanoate Hydrate

    5. Laninamivir Octanoate Hydrate (jan)

    6. Laninamivir Octanoate Hydrate [jan]

    7. Unii-mcg28bi87w

    8. Schembl17728099

    9. Dtxsid70153991

    10. Laninamivir Octanoate Hydrate, (+)-

    11. D09547

    12. Laninamivir Octanoate Monohydrate [who-dd]

    13. Laninamivir Octanoic Acid Ester Hydrate [mi]

    14. Q27283864

    15. (2r,3r,4s)-3-acetamido-4-guanidino-2-((1r,2r)-2-hydroxy-1-methoxy-3-(octanoyloxy)propyl)-3,4-dihydro-2h-pyran-6-carboxylic Acid Monohydrate

    2.4 Create Date
    2010-10-25
    3 Chemical and Physical Properties
    Molecular Weight 490.5 g/mol
    Molecular Formula C21H38N4O9
    Hydrogen Bond Donor Count6
    Hydrogen Bond Acceptor Count10
    Rotatable Bond Count15
    Exact Mass490.26387880 g/mol
    Monoisotopic Mass490.26387880 g/mol
    Topological Polar Surface Area197 Ų
    Heavy Atom Count34
    Formal Charge0
    Complexity723
    Isotope Atom Count0
    Defined Atom Stereocenter Count5
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Antiviral Agents

    Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)